Sign In
Buy BFRG
$0.555
-0.0200 (-3.48%)
At Close: Jul 31, 2026
BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference
04:15pm, Wednesday, 22'nd Jul 2026
GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn com
BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026
04:15pm, Tuesday, 21'st Jul 2026
GAITHERSBURG, Md., July 21, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn com
June 24, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on BullFrog AI Holdings, Inc. (NASDAQ: BFRG) titled, “Helping B
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
08:00am, Tuesday, 02'nd Jun 2026
GAITHERSBURG, Md., June 02, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) an
BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement
07:30am, Wednesday, 22'nd Apr 2026
GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) a
BullFrog AI Announces Participation at AACR Annual Meeting
07:30am, Tuesday, 14'th Apr 2026
BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957 BullFrog AI team will be available to discuss its end-to-end drug discovery and devel
GAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine
Bullfrog AI Holdings Inc. (NASDAQ:BFRG) Short Interest Down 15.0% in March
05:52am, Thursday, 02'nd Apr 2026
Bullfrog AI Holdings Inc. (NASDAQ: BFRG - Get Free Report) was the recipient of a large decline in short interest in March. As of March 13th, there was short interest totaling 550,568 shares, a declin
BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets
09:21am, Tuesday, 31'st Mar 2026
BullFrog said the agreement will utilize its end-to-end analytical AI platform to accelerate the partner's drug discovery and clinical development program for MDD.
Bullfrog AI stock offers a rare opportunity for investors to take profit
04:55pm, Monday, 30'th Mar 2026
Bullfrog AI Inc more than doubled on Mar. 30 after announcing a landmark commercial agreement with a “top 5” pharma leader to identify novel therapeutic targets for Major Depressive Disorder. In i
Dow Gains 200 Points; Bullfrog AI Shares Jump
10:25am, Monday, 30'th Mar 2026
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Monday.
GAITHERSBURG, Md., March 30, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology company using artificial intelligence (“
BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
08:00am, Wednesday, 25'th Mar 2026
Completes end-to-end AI intelligence workflow product with an advanced AI decision tool that clearly defines drug target discovery and clinical trial strategies to build diversified, risk-balanced R&D
BullFrog to Host Webinar on New Precision AI Capability
08:00am, Wednesday, 11'th Mar 2026
March 27 webinar at 11 a.m. ET highlights launch of BullFrog AI's new scenario-based decision engine for pharmaceutical portfolio strategy and clinical trial design March 27 webinar at 11 a.m. ET high
Head to Head Review: Talkspace (NASDAQ:TALK) vs. Bullfrog AI (NASDAQ:BFRG)
04:46am, Saturday, 07'th Mar 2026
Bullfrog AI (NASDAQ: BFRG - Get Free Report) and Talkspace (NASDAQ: TALK - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies
